Literature DB >> 6190077

The discrepancy between the cross-reactivity of a monoclonal antibody to serotonin and its immunohistochemical specificity.

C Milstein, B Wright, A C Cuello.   

Abstract

The rat monoclonal antibody YC5/45 has been shown to react specifically with serotonin containing neurones, and does not detect dopamine containing sites. On the other hand the monoclonal antibody recognizes dopamine, since it is capable of inhibiting the binding of 3H-YC5/45 to sheep red blood cells coated with serotonin albumin conjugate, or the direct agglutination of the same cells by the monoclonal antibody. Tryptamine and 5-methoxytryptamine are even better inhibitors, while derivatives with a modified-CH2-CH2-NH2 group are inactive. Treatment of the active compounds with paraformaldehyde increases their efficiency dramatically. The binding of antibody was also tested by cross linking with paraformaldehyde: dopamine, serotonin, tryptamine, 5-methoxytryptamine etc., to serum albumin. Only the serotonin derivative was active. The result shows that the discrimination specificity observed in immunohistochemistry is due to the paraformaldehyde fixation. It is concluded that for histochemical detection of serotonin by YC5/45, two reactive sites are necessary. The -CH2-CH2-NH2 group is probably modified by formaldehyde to produce a cyclic derivative to form the antibody recognition site. A different formaldehyde reactive site is required for cross linking to the tissue and this is provided by the presence of the 5-OH of serotonin which is absent in the others.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190077     DOI: 10.1016/0161-5890(83)90110-4

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  Argentaffin and argyrophil reactions and serotonin content of endocrine tumours.

Authors:  C A Wells; S M Taylor; A C Cuello
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

2.  Innervation of the gastrointestinal canal of the toad Bufo marinus by neurons containing 5-hydroxytryptamine-like immunoreactivity.

Authors:  C Anderson; G Campbell
Journal:  Cell Tissue Res       Date:  1989-03       Impact factor: 5.249

3.  A new case for a presynaptic role of dendrites: an immunocytochemical study of the n. raphé dorsalis.

Authors:  J Pecci Saavedra; A Brusco; S Peressini; D Oliva
Journal:  Neurochem Res       Date:  1986-07       Impact factor: 3.996

4.  Small intestinal chromaffin cells and carcinoid tumours: a study with silver stains, formalin-induced fluorescence and monoclonal antibodies to serotonin.

Authors:  M Lundqvist; E Wilander
Journal:  Histochem J       Date:  1984-12

5.  S-100 protein in carcinoid tumours of appendix.

Authors:  E Wilander; M Lundqvist; T Movin
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

6.  Localization of serotonin in the hypothalamus and the mesencephalon of the guinea-pig. An immunohistochemical study using monoclonal antibodies.

Authors:  M Warembourg; P Poulain
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

7.  Basis for the specificity of anti-5-HT-like antisera in immunocytochemistry applied to the central nervous system.

Authors:  S Peressini; A Brusco; J Pecci Saavedra
Journal:  Histochemistry       Date:  1984

8.  Anti-5-hydroxytryptamine antibodies: studies on their cross-reactivity in vitro and their immunohistochemical specificity.

Authors:  H Bras; G Chazal; J Destombes; J J Puizillout
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

9.  Fluorescein and tetramethyl rhodamine as haptens in enzyme immunohistochemistry.

Authors:  J J Haaijman; J Coolen; C J Kröse; G J Pronk; Z F Ming
Journal:  Histochemistry       Date:  1986

10.  Further evidence for the specificity of anti-5-HT (serotonin)-like antisera in immunocytochemistry. Existence of cyclic secondary amino groups in the immunogen.

Authors:  C J Tandler; A Brusco; S Peressini; J Pecci Saavedra
Journal:  Histochemistry       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.